Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Many people regard joint pain or stiffness as a natural phenomenon that occurs with age, but caution is needed because it may ...

Signs of immune system aging appear years before rheumatoid arthritis takes hold, offering new hope for early diagnosis and ...

Stevens-Johnson syndrome (SJS) is a rare, severe and potentially fatal allergic reaction that can cause widespread rash, ...

State pensioners suffering from a common condition could claim up to £441 each month thanks to a tax-free benefit. New ...

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

Diagnosing arthritis has always been a challenge, especially when the two most common types—osteoarthritis and rheumatoid arthritis—can look alike. Both diseases lead to joint pain, stiffness, and ...

The first-ever neuroimmune modulation implant has been approved for people with moderate to severe rheumatoid arthritis (RA) who haven't found relief with traditional medications. It's a potentially ...

Rheumatoid arthritis is a chronic inflammatory joint disease with low treatment coverage in sub-Saharan Africa. Effective treatment strategies are available. We aimed to evaluate the cost ...